je.st
news
Tag: biopharmaceuticals
Navidea Biopharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference
2013-04-02 03:59:33| Biotech - Topix.net
Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr.
Tags: present
future
industry
conference
SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
2013-03-27 14:56:00| dairynetwork Home Page
The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder.
Tags: development
companies
chinese
drug
SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
2013-03-27 14:56:00| dairynetwork News Articles
The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder.
Tags: development
companies
chinese
drug
SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
2013-03-27 14:56:00| drugdiscoveryonline News Articles
The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder
Tags: development
companies
chinese
drug
Development & Commercial Services: Biopharmaceuticals
2013-03-06 16:24:48| drugdiscoveryonline Downloads
From having developed over 80 large molecule dose forms, Patheon has extensive experience ranging from early formulation development through to product commercialization. Product development is supported by robust site infrastructure including Bioanalytical laboratories (including cell-based assays) and storage of refrigerated and frozen drug products (-20°C and -70°C). Liquid and lyophilized products are effectively managed using minimal amounts of API.
Tags: services
development
commercial
commercial development